Leading vaccine makers like Eli Lilly and Co. (NYSE: LLY), Pfizer Inc. (NYSE: PFE), and AstraZeneca plc (NASDAQ: AZN) may have faded from the spotlight since the peak of the COVID-19 pandemic ...

The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...

[What you need to know about the Moderna and Pfizer coronavirus vaccines] Researchers in the United States set an audacious goal in January last year to develop a coronavirus vaccine within 12 to ...

AstraZeneca wrote to Pfizer on 12 January rejecting the proposal ... deal announced last week which saw the Novartis swap its vaccines business for GSK's oncology franchise.

The FDA gave Pfizer's RSVpreF (PF-06928316) vaccine the new status – which ... against RSV in the crucial first few months of life. AstraZeneca and Sanofi are leading the charge here with ...

“At the current time, the use of the Pfizer vaccine is preferred over the AstraZeneca vaccine in adults aged less than 50 years who have not already received a first dose of AstraZeneca vaccin ...

Biotech company Immunai, which developed an AI-based immune system mapping technology for drug development, announces the ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor ...